CNTD1
gene geneOn this page
Also known as FLJ40137
Summary
CNTD1 (cyclin N-terminal domain containing 1, HGNC:26847) is a protein-coding gene on chromosome 17q21.2-q21.31, encoding Cyclin N-terminal domain-containing protein 1 (Q8N815). Plays a role in the different steps of crossover formation during meiotic recombination.
Predicted to be involved in reciprocal meiotic recombination and regulation of meiotic cell cycle. Predicted to act upstream of or within spermatogenesis. Predicted to be located in chromosome. Predicted to be active in site of double-strand break.
Source: NCBI Gene 124817 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 42 total
- MANE Select transcript:
NM_173478
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26847 |
| Approved symbol | CNTD1 |
| Name | cyclin N-terminal domain containing 1 |
| Location | 17q21.2-q21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ40137 |
| Ensembl gene | ENSG00000176563 |
| Ensembl biotype | protein_coding |
| OMIM | 618166 |
| Entrez | 124817 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 4 protein_coding, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000315066, ENST00000585355, ENST00000586652, ENST00000588408, ENST00000588527, ENST00000591559, ENST00000592166
RefSeq mRNA: 2 — MANE Select: NM_173478
NM_001330222, NM_173478
CCDS: CCDS11440, CCDS82131
Canonical transcript exons
ENST00000588408 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002794354 | 42798861 | 42799236 |
| ENSE00002966229 | 42809365 | 42811587 |
| ENSE00003461384 | 42804225 | 42804396 |
| ENSE00003558775 | 42807768 | 42807864 |
| ENSE00003582019 | 42806674 | 42806818 |
| ENSE00003606769 | 42805722 | 42805884 |
| ENSE00003666352 | 42803620 | 42803695 |
Expression profiles
Bgee: expression breadth ubiquitous, 167 present calls, max score 92.88.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1041 / max 41.9509, expressed in 21 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 160995 | 0.0575 | 18 |
| 160996 | 0.0140 | 4 |
| 160997 | 0.0108 | 3 |
| 160998 | 0.0092 | 3 |
| 160999 | 0.0072 | 3 |
| 208201 | 0.0055 | 3 |
Top tissues by expression
259 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 92.88 | gold quality |
| right testis | UBERON:0004534 | 92.63 | gold quality |
| testis | UBERON:0000473 | 89.80 | gold quality |
| sperm | CL:0000019 | 87.58 | gold quality |
| bronchial epithelial cell | CL:0002328 | 86.06 | gold quality |
| bronchus | UBERON:0002185 | 84.20 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.86 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.19 | gold quality |
| kidney epithelium | UBERON:0004819 | 76.45 | gold quality |
| body of stomach | UBERON:0001161 | 75.71 | gold quality |
| adult organism | UBERON:0007023 | 75.36 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 75.08 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 74.86 | gold quality |
| right uterine tube | UBERON:0001302 | 73.64 | gold quality |
| stomach | UBERON:0000945 | 72.62 | gold quality |
| rectum | UBERON:0001052 | 72.37 | gold quality |
| metanephros cortex | UBERON:0010533 | 71.73 | gold quality |
| transverse colon | UBERON:0001157 | 71.07 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 71.05 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 70.40 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 70.18 | gold quality |
| spleen | UBERON:0002106 | 69.60 | gold quality |
| body of pancreas | UBERON:0001150 | 69.50 | gold quality |
| mucosa of stomach | UBERON:0001199 | 69.31 | gold quality |
| granulocyte | CL:0000094 | 69.17 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 69.16 | silver quality |
| sural nerve | UBERON:0015488 | 68.39 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 68.32 | gold quality |
| lower esophagus | UBERON:0013473 | 68.30 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 68.28 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-86618 | no | 90.31 |
| E-ANND-3 | no | 3.67 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
123 targeting CNTD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-3134 | 100.00 | 66.43 | 777 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-6768-5P | 99.92 | 67.36 | 1942 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cntd1 | ENSMUSG00000078653 |
| caenorhabditis_elegans | WBGENE00022172 |
Protein
Protein identifiers
Cyclin N-terminal domain-containing protein 1 — Q8N815 (reviewed: Q8N815)
All UniProt accessions (5): B4DXR6, Q8N815, K7ELB6, K7EQE2, K7ERX8
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in the different steps of crossover formation during meiotic recombination. Participates in the crossover differentiation step of crossover-specific recombination intermediates through its interaction with PRR19. In addition, stimulates crossover formation through the interactions with RFC3 and RFC4 and simultaneously regulates cell-cycle progression through interactions with CDC34 and subsequent ubiquitination of WEE1. May also participates in an active deselection process that destabilizes or removes excess pre-CO intermediates.
Subunit / interactions. Interacts with PRR19; this interaction promotes crossover formation. Interacts with RFC3 and RFC4; these interactions facilitate crossover formation. Interacts with CDC34; this interaction regulates the cell-cycle progression.
Subcellular location. Nucleus. Cytoplasm. Chromosome.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N815-1 | 1 | yes |
| Q8N815-2 | 2 |
RefSeq proteins (2): NP_001317151, NP_775749* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006671 | Cyclin_N | Domain |
| IPR036915 | Cyclin-like_sf | Homologous_superfamily |
Pfam: PF00134
UniProt features (5 total): chain 1, domain 1, splice variant 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N815-F1 | 84.94 | 0.62 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 132 (showing top):
RACCACAR_AML_Q6, GOBP_MALE_GAMETE_GENERATION, GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE, CAGCTG_AP4_Q5, GOBP_ORGANELLE_FISSION, RGTTAMWNATT_HNF1_01, GOBP_REGULATION_OF_CELL_CYCLE, GOBP_REGULATION_OF_REPRODUCTIVE_PROCESS, TGANTCA_AP1_C, HNF1_C, TGGNNNNNNKCCAR_UNKNOWN, TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, PTF1BETA_Q6
GO Biological Process (4): reciprocal meiotic recombination (GO:0007131), spermatogenesis (GO:0007283), regulation of meiotic cell cycle (GO:0051445), meiotic cell cycle (GO:0051321)
GO Molecular Function (0):
GO Cellular Component (4): nucleus (GO:0005634), chromosome (GO:0005694), cytoplasm (GO:0005737), site of double-strand break (GO:0035861)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| meiosis I | 1 |
| reciprocal homologous recombination | 1 |
| meiotic cell cycle process | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| meiotic cell cycle | 1 |
| regulation of cell cycle | 1 |
| regulation of reproductive process | 1 |
| cell cycle | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| meiotic nuclear division | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| site of DNA damage | 1 |
Protein interactions and networks
STRING
488 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CNTD1 | RNF212 | Q495C1 | 833 |
| CNTD1 | SPO11 | Q9Y5K1 | 762 |
| CNTD1 | MSH5 | O43196 | 750 |
| CNTD1 | UNC119 | Q13432 | 741 |
| CNTD1 | MSH4 | O15457 | 707 |
| CNTD1 | SUN1 | O94901 | 626 |
| CNTD1 | PPIE | Q9UNP9 | 620 |
| CNTD1 | CCNB1IP1 | Q9NPC3 | 606 |
| CNTD1 | RAD51 | Q06609 | 565 |
| CNTD1 | MUS81 | Q96NY9 | 490 |
| CNTD1 | PRR19 | A6NJB7 | 477 |
| CNTD1 | PLK2 | Q9NYY3 | 471 |
| CNTD1 | RTEL1 | Q9NZ71 | 445 |
| CNTD1 | HORMAD1 | Q86X24 | 440 |
| CNTD1 | SLX1A | Q9BQ83 | 437 |
IntAct
0 interactions, top by confidence:
BioGRID (4): CNTD1 (Reconstituted Complex), CNTD1 (Affinity Capture-MS), CNTD1 (Affinity Capture-MS), SYNPO2L (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A5PK16, O08918, O42575, O96020, P24385, P24864, P25322, P30279, P30280, P30282, P39948, P39949, P39950, P41002, P47794, P48961, P49706, P49707, P50755, P50756, P51944, P51945, P51959, P53782, P55169, Q04827, Q0P5D3, Q16589, Q2KI22, Q32NJ2, Q32NM1, Q52QT8, Q5E9I1, Q5E9K7, Q5R5D0, Q5R6J5, Q5SRT8, Q5T5M9, Q5XGG5, Q61457
Diamond homologs: Q8N815, Q9D995
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
42 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 33 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1219 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:42799182:GCA:G | donor_gain | 1.0000 |
| 17:42805810:TTTTG:T | donor_gain | 1.0000 |
| 17:42805877:GGTTT:G | donor_gain | 1.0000 |
| 17:42810924:CCATC:C | acceptor_gain | 1.0000 |
| 17:42810925:CATC:C | acceptor_gain | 1.0000 |
| 17:42810925:CATCC:C | acceptor_gain | 1.0000 |
| 17:42810926:ATCC:A | acceptor_loss | 1.0000 |
| 17:42810927:TC:T | acceptor_gain | 1.0000 |
| 17:42810927:TCCTG:T | acceptor_loss | 1.0000 |
| 17:42810928:CC:C | acceptor_gain | 1.0000 |
| 17:42810929:C:CC | acceptor_gain | 1.0000 |
| 17:42810929:C:CG | acceptor_loss | 1.0000 |
| 17:42810930:T:A | acceptor_loss | 1.0000 |
| 17:42810935:A:AC | acceptor_gain | 1.0000 |
| 17:42799179:C:T | donor_gain | 0.9900 |
| 17:42799185:G:GG | donor_gain | 0.9900 |
| 17:42799190:G:GT | donor_gain | 0.9900 |
| 17:42799191:G:T | donor_gain | 0.9900 |
| 17:42799220:G:GT | donor_gain | 0.9900 |
| 17:42799229:GATC:G | donor_gain | 0.9900 |
| 17:42804397:G:GG | donor_gain | 0.9900 |
| 17:42805719:CA:C | acceptor_loss | 0.9900 |
| 17:42805720:A:AG | acceptor_gain | 0.9900 |
| 17:42805720:A:T | acceptor_loss | 0.9900 |
| 17:42805721:G:GC | acceptor_loss | 0.9900 |
| 17:42805721:G:GG | acceptor_gain | 0.9900 |
| 17:42805721:GAT:G | acceptor_gain | 0.9900 |
| 17:42805721:GATA:G | acceptor_gain | 0.9900 |
| 17:42805814:G:GT | donor_gain | 0.9900 |
| 17:42805854:GCA:G | donor_gain | 0.9900 |
AlphaMissense
2138 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:42807829:A:C | S263R | 0.991 |
| 17:42807831:T:A | S263R | 0.991 |
| 17:42807831:T:G | S263R | 0.991 |
| 17:42803676:G:C | A76P | 0.987 |
| 17:42804226:T:C | F83L | 0.987 |
| 17:42804228:T:A | F83L | 0.987 |
| 17:42804228:T:G | F83L | 0.987 |
| 17:42805827:T:C | F175L | 0.982 |
| 17:42805829:C:A | F175L | 0.982 |
| 17:42805829:C:G | F175L | 0.982 |
| 17:42804358:T:C | C127R | 0.978 |
| 17:42805797:T:C | S165P | 0.978 |
| 17:42804360:T:G | C127W | 0.977 |
| 17:42804362:T:A | V128D | 0.975 |
| 17:42806720:C:G | C209W | 0.975 |
| 17:42805801:A:T | E166V | 0.974 |
| 17:42807814:G:A | G258R | 0.974 |
| 17:42807814:G:C | G258R | 0.974 |
| 17:42804378:A:C | K133N | 0.973 |
| 17:42804378:A:T | K133N | 0.973 |
| 17:42807809:C:A | A256E | 0.973 |
| 17:42807793:G:C | D251H | 0.972 |
| 17:42804359:G:A | C127Y | 0.968 |
| 17:42806718:T:C | C209R | 0.968 |
| 17:42804373:A:C | S132R | 0.967 |
| 17:42804375:C:A | S132R | 0.967 |
| 17:42804375:C:G | S132R | 0.967 |
| 17:42805804:T:C | L167P | 0.966 |
| 17:42804371:C:A | A131D | 0.965 |
| 17:42805810:T:A | V169D | 0.965 |
dbSNP variants (sampled 300 via entrez): RS1000182241 (17:42808610 C>T), RS1000388767 (17:42800324 T>C), RS1000402486 (17:42808960 G>A), RS1000508480 (17:42807143 C>T), RS1000665020 (17:42799680 A>T), RS1000728431 (17:42807295 G>A), RS1001127334 (17:42798636 C>G,T), RS1001332053 (17:42803762 A>G), RS1001342277 (17:42802505 C>T), RS1001403750 (17:42803253 C>T), RS1001792122 (17:42802796 T>C), RS1002139851 (17:42804246 G>A), RS1002333185 (17:42801229 C>T), RS1002953265 (17:42797281 C>A,T), RS1003039782 (17:42805253 A>G)
Disease associations
OMIM: gene MIM:618166 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004125_13 | Type 2 diabetes (age of onset) | 3.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Allergens | decreases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.